Global Bio Similars/Subsequent Entry Biologic Market Growth (Status and Outlook) 2022-2028
The report requires updating with new data and is sent in 48 hours after order is placed.
As the global economy mends, the 2021 growth of Bio Similars/Subsequent Entry Biologic will have significant change from previous year. According to our (LP Information) latest study, the global Bio Similars/Subsequent Entry Biologic market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Bio Similars/Subsequent Entry Biologic market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.
The United States Bio Similars/Subsequent Entry Biologic market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Bio Similars/Subsequent Entry Biologic market, reaching US$ million by the year 2028. As for the Europe Bio Similars/Subsequent Entry Biologic landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Bio Similars/Subsequent Entry Biologic players cover Sun Pharma, Synthon Pharmaceuticals, Teva Pharmaceutical Industries, and LG Life Sciences, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Bio Similars/Subsequent Entry Biologic market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
As the global economy mends, the 2021 growth of Bio Similars/Subsequent Entry Biologic will have significant change from previous year. According to our (LP Information) latest study, the global Bio Similars/Subsequent Entry Biologic market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Bio Similars/Subsequent Entry Biologic market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.
The United States Bio Similars/Subsequent Entry Biologic market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Bio Similars/Subsequent Entry Biologic market, reaching US$ million by the year 2028. As for the Europe Bio Similars/Subsequent Entry Biologic landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Bio Similars/Subsequent Entry Biologic players cover Sun Pharma, Synthon Pharmaceuticals, Teva Pharmaceutical Industries, and LG Life Sciences, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Bio Similars/Subsequent Entry Biologic market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
- Monoclonal Antibodies
- Interferon
- Erythropoietin
- Insulin
- Vaccines
- Other
- Tumor
- Diabetes
- Cardiovascular
- Hemophilia
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Sun Pharma
- Synthon Pharmaceuticals
- Teva Pharmaceutical Industries
- LG Life Sciences
- Celltrion Biocon
- Hospira
- Merck
- Biogen idec
- Genentech (Roche)
- Pfizer
- Celltrion
- Biocon
- Amgen
- Samsung Biologics
- Mylan
- Dr. Reddy's Laboratories
- Stada Arzneimittel AG
- AbbVie
- Sanofi-Aventis
- Johnson & Johnson
- Novo Nordisk
- Eli Lilly
- Novartis
- 3sbio
- Biotech
- Gelgen
- Innovent
- Dong Bao
- Ganlee
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Bio Similars/Subsequent Entry Biologic Market Size 2017-2028
2.1.2 Bio Similars/Subsequent Entry Biologic Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Bio Similars/Subsequent Entry Biologic Segment by Type
2.2.1 Monoclonal Antibodies
2.2.2 Interferon
2.2.3 Erythropoietin
2.2.4 Insulin
2.2.5 Vaccines
2.2.6 Other
2.3 Bio Similars/Subsequent Entry Biologic Market Size by Type
2.3.1 Bio Similars/Subsequent Entry Biologic Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Bio Similars/Subsequent Entry Biologic Market Size Market Share by Type (2017-2022)
2.4 Bio Similars/Subsequent Entry Biologic Segment by Application
2.4.1 Tumor
2.4.2 Diabetes
2.4.3 Cardiovascular
2.4.4 Hemophilia
2.4.5 Other
2.5 Bio Similars/Subsequent Entry Biologic Market Size by Application
2.5.1 Bio Similars/Subsequent Entry Biologic Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Bio Similars/Subsequent Entry Biologic Market Size Market Share by Application (2017-2022)
3 BIO SIMILARS/SUBSEQUENT ENTRY BIOLOGIC MARKET SIZE BY PLAYER
3.1 Bio Similars/Subsequent Entry Biologic Market Size Market Share by Players
3.1.1 Global Bio Similars/Subsequent Entry Biologic Revenue by Players (2020-2022)
3.1.2 Global Bio Similars/Subsequent Entry Biologic Revenue Market Share by Players (2020-2022)
3.2 Global Bio Similars/Subsequent Entry Biologic Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 BIO SIMILARS/SUBSEQUENT ENTRY BIOLOGIC BY REGIONS
4.1 Bio Similars/Subsequent Entry Biologic Market Size by Regions (2017-2022)
4.2 Americas Bio Similars/Subsequent Entry Biologic Market Size Growth (2017-2022)
4.3 APAC Bio Similars/Subsequent Entry Biologic Market Size Growth (2017-2022)
4.4 Europe Bio Similars/Subsequent Entry Biologic Market Size Growth (2017-2022)
4.5 Middle East & Africa Bio Similars/Subsequent Entry Biologic Market Size Growth (2017-2022)
5 AMERICAS
5.1 Americas Bio Similars/Subsequent Entry Biologic Market Size by Country (2017-2022)
5.2 Americas Bio Similars/Subsequent Entry Biologic Market Size by Type (2017-2022)
5.3 Americas Bio Similars/Subsequent Entry Biologic Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Bio Similars/Subsequent Entry Biologic Market Size by Region (2017-2022)
6.2 APAC Bio Similars/Subsequent Entry Biologic Market Size by Type (2017-2022)
6.3 APAC Bio Similars/Subsequent Entry Biologic Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Bio Similars/Subsequent Entry Biologic by Country (2017-2022)
7.2 Europe Bio Similars/Subsequent Entry Biologic Market Size by Type (2017-2022)
7.3 Europe Bio Similars/Subsequent Entry Biologic Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Bio Similars/Subsequent Entry Biologic by Region (2017-2022)
8.2 Middle East & Africa Bio Similars/Subsequent Entry Biologic Market Size by Type (2017-2022)
8.3 Middle East & Africa Bio Similars/Subsequent Entry Biologic Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL BIO SIMILARS/SUBSEQUENT ENTRY BIOLOGIC MARKET FORECAST
10.1 Global Bio Similars/Subsequent Entry Biologic Forecast by Regions (2023-2028)
10.1.1 Global Bio Similars/Subsequent Entry Biologic Forecast by Regions (2023-2028)
10.1.2 Americas Bio Similars/Subsequent Entry Biologic Forecast
10.1.3 APAC Bio Similars/Subsequent Entry Biologic Forecast
10.1.4 Europe Bio Similars/Subsequent Entry Biologic Forecast
10.1.5 Middle East & Africa Bio Similars/Subsequent Entry Biologic Forecast
10.2 Americas Bio Similars/Subsequent Entry Biologic Forecast by Country (2023-2028)
10.2.1 United States Bio Similars/Subsequent Entry Biologic Market Forecast
10.2.2 Canada Bio Similars/Subsequent Entry Biologic Market Forecast
10.2.3 Mexico Bio Similars/Subsequent Entry Biologic Market Forecast
10.2.4 Brazil Bio Similars/Subsequent Entry Biologic Market Forecast
10.3 APAC Bio Similars/Subsequent Entry Biologic Forecast by Region (2023-2028)
10.3.1 China Bio Similars/Subsequent Entry Biologic Market Forecast
10.3.2 Japan Bio Similars/Subsequent Entry Biologic Market Forecast
10.3.3 Korea Bio Similars/Subsequent Entry Biologic Market Forecast
10.3.4 Southeast Asia Bio Similars/Subsequent Entry Biologic Market Forecast
10.3.5 India Bio Similars/Subsequent Entry Biologic Market Forecast
10.3.6 Australia Bio Similars/Subsequent Entry Biologic Market Forecast
10.4 Europe Bio Similars/Subsequent Entry Biologic Forecast by Country (2023-2028)
10.4.1 Germany Bio Similars/Subsequent Entry Biologic Market Forecast
10.4.2 France Bio Similars/Subsequent Entry Biologic Market Forecast
10.4.3 UK Bio Similars/Subsequent Entry Biologic Market Forecast
10.4.4 Italy Bio Similars/Subsequent Entry Biologic Market Forecast
10.4.5 Russia Bio Similars/Subsequent Entry Biologic Market Forecast
10.5 Middle East & Africa Bio Similars/Subsequent Entry Biologic Forecast by Region (2023-2028)
10.5.1 Egypt Bio Similars/Subsequent Entry Biologic Market Forecast
10.5.2 South Africa Bio Similars/Subsequent Entry Biologic Market Forecast
10.5.3 Israel Bio Similars/Subsequent Entry Biologic Market Forecast
10.5.4 Turkey Bio Similars/Subsequent Entry Biologic Market Forecast
10.5.5 GCC Countries Bio Similars/Subsequent Entry Biologic Market Forecast
10.6 Global Bio Similars/Subsequent Entry Biologic Forecast by Type (2023-2028)
10.7 Global Bio Similars/Subsequent Entry Biologic Forecast by Application (2023-2028)
11 KEY PLAYERS ANALYSIS
11.1 Sun Pharma
11.1.1 Sun Pharma Company Information
11.1.2 Sun Pharma Bio Similars/Subsequent Entry Biologic Product Offered
11.1.3 Sun Pharma Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Sun Pharma Main Business Overview
11.1.5 Sun Pharma Latest Developments
11.2 Synthon Pharmaceuticals
11.2.1 Synthon Pharmaceuticals Company Information
11.2.2 Synthon Pharmaceuticals Bio Similars/Subsequent Entry Biologic Product Offered
11.2.3 Synthon Pharmaceuticals Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Synthon Pharmaceuticals Main Business Overview
11.2.5 Synthon Pharmaceuticals Latest Developments
11.3 Teva Pharmaceutical Industries
11.3.1 Teva Pharmaceutical Industries Company Information
11.3.2 Teva Pharmaceutical Industries Bio Similars/Subsequent Entry Biologic Product Offered
11.3.3 Teva Pharmaceutical Industries Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Teva Pharmaceutical Industries Main Business Overview
11.3.5 Teva Pharmaceutical Industries Latest Developments
11.4 LG Life Sciences
11.4.1 LG Life Sciences Company Information
11.4.2 LG Life Sciences Bio Similars/Subsequent Entry Biologic Product Offered
11.4.3 LG Life Sciences Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 LG Life Sciences Main Business Overview
11.4.5 LG Life Sciences Latest Developments
11.5 Celltrion Biocon
11.5.1 Celltrion Biocon Company Information
11.5.2 Celltrion Biocon Bio Similars/Subsequent Entry Biologic Product Offered
11.5.3 Celltrion Biocon Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Celltrion Biocon Main Business Overview
11.5.5 Celltrion Biocon Latest Developments
11.6 Hospira
11.6.1 Hospira Company Information
11.6.2 Hospira Bio Similars/Subsequent Entry Biologic Product Offered
11.6.3 Hospira Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 Hospira Main Business Overview
11.6.5 Hospira Latest Developments
11.7 Merck
11.7.1 Merck Company Information
11.7.2 Merck Bio Similars/Subsequent Entry Biologic Product Offered
11.7.3 Merck Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 Merck Main Business Overview
11.7.5 Merck Latest Developments
11.8 Biogen idec
11.8.1 Biogen idec Company Information
11.8.2 Biogen idec Bio Similars/Subsequent Entry Biologic Product Offered
11.8.3 Biogen idec Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 Biogen idec Main Business Overview
11.8.5 Biogen idec Latest Developments
11.9 Genentech (Roche)
11.9.1 Genentech (Roche) Company Information
11.9.2 Genentech (Roche) Bio Similars/Subsequent Entry Biologic Product Offered
11.9.3 Genentech (Roche) Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2020-2022)
11.9.4 Genentech (Roche) Main Business Overview
11.9.5 Genentech (Roche) Latest Developments
11.10 Pfizer
11.10.1 Pfizer Company Information
11.10.2 Pfizer Bio Similars/Subsequent Entry Biologic Product Offered
11.10.3 Pfizer Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2020-2022)
11.10.4 Pfizer Main Business Overview
11.10.5 Pfizer Latest Developments
11.11 Celltrion
11.11.1 Celltrion Company Information
11.11.2 Celltrion Bio Similars/Subsequent Entry Biologic Product Offered
11.11.3 Celltrion Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2020-2022)
11.11.4 Celltrion Main Business Overview
11.11.5 Celltrion Latest Developments
11.12 Biocon
11.12.1 Biocon Company Information
11.12.2 Biocon Bio Similars/Subsequent Entry Biologic Product Offered
11.12.3 Biocon Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2020-2022)
11.12.4 Biocon Main Business Overview
11.12.5 Biocon Latest Developments
11.13 Amgen
11.13.1 Amgen Company Information
11.13.2 Amgen Bio Similars/Subsequent Entry Biologic Product Offered
11.13.3 Amgen Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2020-2022)
11.13.4 Amgen Main Business Overview
11.13.5 Amgen Latest Developments
11.14 Samsung Biologics
11.14.1 Samsung Biologics Company Information
11.14.2 Samsung Biologics Bio Similars/Subsequent Entry Biologic Product Offered
11.14.3 Samsung Biologics Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2020-2022)
11.14.4 Samsung Biologics Main Business Overview
11.14.5 Samsung Biologics Latest Developments
11.15 Mylan
11.15.1 Mylan Company Information
11.15.2 Mylan Bio Similars/Subsequent Entry Biologic Product Offered
11.15.3 Mylan Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2020-2022)
11.15.4 Mylan Main Business Overview
11.15.5 Mylan Latest Developments
11.16 Dr. Reddy's Laboratories
11.16.1 Dr. Reddy's Laboratories Company Information
11.16.2 Dr. Reddy's Laboratories Bio Similars/Subsequent Entry Biologic Product Offered
11.16.3 Dr. Reddy's Laboratories Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2020-2022)
11.16.4 Dr. Reddy's Laboratories Main Business Overview
11.16.5 Dr. Reddy's Laboratories Latest Developments
11.17 Stada Arzneimittel AG
11.17.1 Stada Arzneimittel AG Company Information
11.17.2 Stada Arzneimittel AG Bio Similars/Subsequent Entry Biologic Product Offered
11.17.3 Stada Arzneimittel AG Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2020-2022)
11.17.4 Stada Arzneimittel AG Main Business Overview
11.17.5 Stada Arzneimittel AG Latest Developments
11.18 AbbVie
11.18.1 AbbVie Company Information
11.18.2 AbbVie Bio Similars/Subsequent Entry Biologic Product Offered
11.18.3 AbbVie Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2020-2022)
11.18.4 AbbVie Main Business Overview
11.18.5 AbbVie Latest Developments
11.19 Sanofi-Aventis
11.19.1 Sanofi-Aventis Company Information
11.19.2 Sanofi-Aventis Bio Similars/Subsequent Entry Biologic Product Offered
11.19.3 Sanofi-Aventis Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2020-2022)
11.19.4 Sanofi-Aventis Main Business Overview
11.19.5 Sanofi-Aventis Latest Developments
11.20 Johnson & Johnson
11.20.1 Johnson & Johnson Company Information
11.20.2 Johnson & Johnson Bio Similars/Subsequent Entry Biologic Product Offered
11.20.3 Johnson & Johnson Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2020-2022)
11.20.4 Johnson & Johnson Main Business Overview
11.20.5 Johnson & Johnson Latest Developments
11.21 Novo Nordisk
11.21.1 Novo Nordisk Company Information
11.21.2 Novo Nordisk Bio Similars/Subsequent Entry Biologic Product Offered
11.21.3 Novo Nordisk Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2020-2022)
11.21.4 Novo Nordisk Main Business Overview
11.21.5 Novo Nordisk Latest Developments
11.22 Eli Lilly
11.22.1 Eli Lilly Company Information
11.22.2 Eli Lilly Bio Similars/Subsequent Entry Biologic Product Offered
11.22.3 Eli Lilly Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2020-2022)
11.22.4 Eli Lilly Main Business Overview
11.22.5 Eli Lilly Latest Developments
11.23 Novartis
11.23.1 Novartis Company Information
11.23.2 Novartis Bio Similars/Subsequent Entry Biologic Product Offered
11.23.3 Novartis Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2020-2022)
11.23.4 Novartis Main Business Overview
11.23.5 Novartis Latest Developments
11.24 3sbio
11.24.1 3sbio Company Information
11.24.2 3sbio Bio Similars/Subsequent Entry Biologic Product Offered
11.24.3 3sbio Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2020-2022)
11.24.4 3sbio Main Business Overview
11.24.5 3sbio Latest Developments
11.25 Biotech
11.25.1 Biotech Company Information
11.25.2 Biotech Bio Similars/Subsequent Entry Biologic Product Offered
11.25.3 Biotech Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2020-2022)
11.25.4 Biotech Main Business Overview
11.25.5 Biotech Latest Developments
11.26 Gelgen
11.26.1 Gelgen Company Information
11.26.2 Gelgen Bio Similars/Subsequent Entry Biologic Product Offered
11.26.3 Gelgen Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2020-2022)
11.26.4 Gelgen Main Business Overview
11.26.5 Gelgen Latest Developments
11.27 Innovent
11.27.1 Innovent Company Information
11.27.2 Innovent Bio Similars/Subsequent Entry Biologic Product Offered
11.27.3 Innovent Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2020-2022)
11.27.4 Innovent Main Business Overview
11.27.5 Innovent Latest Developments
11.28 Dong Bao
11.28.1 Dong Bao Company Information
11.28.2 Dong Bao Bio Similars/Subsequent Entry Biologic Product Offered
11.28.3 Dong Bao Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2020-2022)
11.28.4 Dong Bao Main Business Overview
11.28.5 Dong Bao Latest Developments
11.29 Ganlee
11.29.1 Ganlee Company Information
11.29.2 Ganlee Bio Similars/Subsequent Entry Biologic Product Offered
11.29.3 Ganlee Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2020-2022)
11.29.4 Ganlee Main Business Overview
11.29.5 Ganlee Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Bio Similars/Subsequent Entry Biologic Market Size 2017-2028
2.1.2 Bio Similars/Subsequent Entry Biologic Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Bio Similars/Subsequent Entry Biologic Segment by Type
2.2.1 Monoclonal Antibodies
2.2.2 Interferon
2.2.3 Erythropoietin
2.2.4 Insulin
2.2.5 Vaccines
2.2.6 Other
2.3 Bio Similars/Subsequent Entry Biologic Market Size by Type
2.3.1 Bio Similars/Subsequent Entry Biologic Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Bio Similars/Subsequent Entry Biologic Market Size Market Share by Type (2017-2022)
2.4 Bio Similars/Subsequent Entry Biologic Segment by Application
2.4.1 Tumor
2.4.2 Diabetes
2.4.3 Cardiovascular
2.4.4 Hemophilia
2.4.5 Other
2.5 Bio Similars/Subsequent Entry Biologic Market Size by Application
2.5.1 Bio Similars/Subsequent Entry Biologic Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Bio Similars/Subsequent Entry Biologic Market Size Market Share by Application (2017-2022)
3 BIO SIMILARS/SUBSEQUENT ENTRY BIOLOGIC MARKET SIZE BY PLAYER
3.1 Bio Similars/Subsequent Entry Biologic Market Size Market Share by Players
3.1.1 Global Bio Similars/Subsequent Entry Biologic Revenue by Players (2020-2022)
3.1.2 Global Bio Similars/Subsequent Entry Biologic Revenue Market Share by Players (2020-2022)
3.2 Global Bio Similars/Subsequent Entry Biologic Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 BIO SIMILARS/SUBSEQUENT ENTRY BIOLOGIC BY REGIONS
4.1 Bio Similars/Subsequent Entry Biologic Market Size by Regions (2017-2022)
4.2 Americas Bio Similars/Subsequent Entry Biologic Market Size Growth (2017-2022)
4.3 APAC Bio Similars/Subsequent Entry Biologic Market Size Growth (2017-2022)
4.4 Europe Bio Similars/Subsequent Entry Biologic Market Size Growth (2017-2022)
4.5 Middle East & Africa Bio Similars/Subsequent Entry Biologic Market Size Growth (2017-2022)
5 AMERICAS
5.1 Americas Bio Similars/Subsequent Entry Biologic Market Size by Country (2017-2022)
5.2 Americas Bio Similars/Subsequent Entry Biologic Market Size by Type (2017-2022)
5.3 Americas Bio Similars/Subsequent Entry Biologic Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Bio Similars/Subsequent Entry Biologic Market Size by Region (2017-2022)
6.2 APAC Bio Similars/Subsequent Entry Biologic Market Size by Type (2017-2022)
6.3 APAC Bio Similars/Subsequent Entry Biologic Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Bio Similars/Subsequent Entry Biologic by Country (2017-2022)
7.2 Europe Bio Similars/Subsequent Entry Biologic Market Size by Type (2017-2022)
7.3 Europe Bio Similars/Subsequent Entry Biologic Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Bio Similars/Subsequent Entry Biologic by Region (2017-2022)
8.2 Middle East & Africa Bio Similars/Subsequent Entry Biologic Market Size by Type (2017-2022)
8.3 Middle East & Africa Bio Similars/Subsequent Entry Biologic Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL BIO SIMILARS/SUBSEQUENT ENTRY BIOLOGIC MARKET FORECAST
10.1 Global Bio Similars/Subsequent Entry Biologic Forecast by Regions (2023-2028)
10.1.1 Global Bio Similars/Subsequent Entry Biologic Forecast by Regions (2023-2028)
10.1.2 Americas Bio Similars/Subsequent Entry Biologic Forecast
10.1.3 APAC Bio Similars/Subsequent Entry Biologic Forecast
10.1.4 Europe Bio Similars/Subsequent Entry Biologic Forecast
10.1.5 Middle East & Africa Bio Similars/Subsequent Entry Biologic Forecast
10.2 Americas Bio Similars/Subsequent Entry Biologic Forecast by Country (2023-2028)
10.2.1 United States Bio Similars/Subsequent Entry Biologic Market Forecast
10.2.2 Canada Bio Similars/Subsequent Entry Biologic Market Forecast
10.2.3 Mexico Bio Similars/Subsequent Entry Biologic Market Forecast
10.2.4 Brazil Bio Similars/Subsequent Entry Biologic Market Forecast
10.3 APAC Bio Similars/Subsequent Entry Biologic Forecast by Region (2023-2028)
10.3.1 China Bio Similars/Subsequent Entry Biologic Market Forecast
10.3.2 Japan Bio Similars/Subsequent Entry Biologic Market Forecast
10.3.3 Korea Bio Similars/Subsequent Entry Biologic Market Forecast
10.3.4 Southeast Asia Bio Similars/Subsequent Entry Biologic Market Forecast
10.3.5 India Bio Similars/Subsequent Entry Biologic Market Forecast
10.3.6 Australia Bio Similars/Subsequent Entry Biologic Market Forecast
10.4 Europe Bio Similars/Subsequent Entry Biologic Forecast by Country (2023-2028)
10.4.1 Germany Bio Similars/Subsequent Entry Biologic Market Forecast
10.4.2 France Bio Similars/Subsequent Entry Biologic Market Forecast
10.4.3 UK Bio Similars/Subsequent Entry Biologic Market Forecast
10.4.4 Italy Bio Similars/Subsequent Entry Biologic Market Forecast
10.4.5 Russia Bio Similars/Subsequent Entry Biologic Market Forecast
10.5 Middle East & Africa Bio Similars/Subsequent Entry Biologic Forecast by Region (2023-2028)
10.5.1 Egypt Bio Similars/Subsequent Entry Biologic Market Forecast
10.5.2 South Africa Bio Similars/Subsequent Entry Biologic Market Forecast
10.5.3 Israel Bio Similars/Subsequent Entry Biologic Market Forecast
10.5.4 Turkey Bio Similars/Subsequent Entry Biologic Market Forecast
10.5.5 GCC Countries Bio Similars/Subsequent Entry Biologic Market Forecast
10.6 Global Bio Similars/Subsequent Entry Biologic Forecast by Type (2023-2028)
10.7 Global Bio Similars/Subsequent Entry Biologic Forecast by Application (2023-2028)
11 KEY PLAYERS ANALYSIS
11.1 Sun Pharma
11.1.1 Sun Pharma Company Information
11.1.2 Sun Pharma Bio Similars/Subsequent Entry Biologic Product Offered
11.1.3 Sun Pharma Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Sun Pharma Main Business Overview
11.1.5 Sun Pharma Latest Developments
11.2 Synthon Pharmaceuticals
11.2.1 Synthon Pharmaceuticals Company Information
11.2.2 Synthon Pharmaceuticals Bio Similars/Subsequent Entry Biologic Product Offered
11.2.3 Synthon Pharmaceuticals Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Synthon Pharmaceuticals Main Business Overview
11.2.5 Synthon Pharmaceuticals Latest Developments
11.3 Teva Pharmaceutical Industries
11.3.1 Teva Pharmaceutical Industries Company Information
11.3.2 Teva Pharmaceutical Industries Bio Similars/Subsequent Entry Biologic Product Offered
11.3.3 Teva Pharmaceutical Industries Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Teva Pharmaceutical Industries Main Business Overview
11.3.5 Teva Pharmaceutical Industries Latest Developments
11.4 LG Life Sciences
11.4.1 LG Life Sciences Company Information
11.4.2 LG Life Sciences Bio Similars/Subsequent Entry Biologic Product Offered
11.4.3 LG Life Sciences Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 LG Life Sciences Main Business Overview
11.4.5 LG Life Sciences Latest Developments
11.5 Celltrion Biocon
11.5.1 Celltrion Biocon Company Information
11.5.2 Celltrion Biocon Bio Similars/Subsequent Entry Biologic Product Offered
11.5.3 Celltrion Biocon Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Celltrion Biocon Main Business Overview
11.5.5 Celltrion Biocon Latest Developments
11.6 Hospira
11.6.1 Hospira Company Information
11.6.2 Hospira Bio Similars/Subsequent Entry Biologic Product Offered
11.6.3 Hospira Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 Hospira Main Business Overview
11.6.5 Hospira Latest Developments
11.7 Merck
11.7.1 Merck Company Information
11.7.2 Merck Bio Similars/Subsequent Entry Biologic Product Offered
11.7.3 Merck Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 Merck Main Business Overview
11.7.5 Merck Latest Developments
11.8 Biogen idec
11.8.1 Biogen idec Company Information
11.8.2 Biogen idec Bio Similars/Subsequent Entry Biologic Product Offered
11.8.3 Biogen idec Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 Biogen idec Main Business Overview
11.8.5 Biogen idec Latest Developments
11.9 Genentech (Roche)
11.9.1 Genentech (Roche) Company Information
11.9.2 Genentech (Roche) Bio Similars/Subsequent Entry Biologic Product Offered
11.9.3 Genentech (Roche) Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2020-2022)
11.9.4 Genentech (Roche) Main Business Overview
11.9.5 Genentech (Roche) Latest Developments
11.10 Pfizer
11.10.1 Pfizer Company Information
11.10.2 Pfizer Bio Similars/Subsequent Entry Biologic Product Offered
11.10.3 Pfizer Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2020-2022)
11.10.4 Pfizer Main Business Overview
11.10.5 Pfizer Latest Developments
11.11 Celltrion
11.11.1 Celltrion Company Information
11.11.2 Celltrion Bio Similars/Subsequent Entry Biologic Product Offered
11.11.3 Celltrion Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2020-2022)
11.11.4 Celltrion Main Business Overview
11.11.5 Celltrion Latest Developments
11.12 Biocon
11.12.1 Biocon Company Information
11.12.2 Biocon Bio Similars/Subsequent Entry Biologic Product Offered
11.12.3 Biocon Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2020-2022)
11.12.4 Biocon Main Business Overview
11.12.5 Biocon Latest Developments
11.13 Amgen
11.13.1 Amgen Company Information
11.13.2 Amgen Bio Similars/Subsequent Entry Biologic Product Offered
11.13.3 Amgen Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2020-2022)
11.13.4 Amgen Main Business Overview
11.13.5 Amgen Latest Developments
11.14 Samsung Biologics
11.14.1 Samsung Biologics Company Information
11.14.2 Samsung Biologics Bio Similars/Subsequent Entry Biologic Product Offered
11.14.3 Samsung Biologics Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2020-2022)
11.14.4 Samsung Biologics Main Business Overview
11.14.5 Samsung Biologics Latest Developments
11.15 Mylan
11.15.1 Mylan Company Information
11.15.2 Mylan Bio Similars/Subsequent Entry Biologic Product Offered
11.15.3 Mylan Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2020-2022)
11.15.4 Mylan Main Business Overview
11.15.5 Mylan Latest Developments
11.16 Dr. Reddy's Laboratories
11.16.1 Dr. Reddy's Laboratories Company Information
11.16.2 Dr. Reddy's Laboratories Bio Similars/Subsequent Entry Biologic Product Offered
11.16.3 Dr. Reddy's Laboratories Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2020-2022)
11.16.4 Dr. Reddy's Laboratories Main Business Overview
11.16.5 Dr. Reddy's Laboratories Latest Developments
11.17 Stada Arzneimittel AG
11.17.1 Stada Arzneimittel AG Company Information
11.17.2 Stada Arzneimittel AG Bio Similars/Subsequent Entry Biologic Product Offered
11.17.3 Stada Arzneimittel AG Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2020-2022)
11.17.4 Stada Arzneimittel AG Main Business Overview
11.17.5 Stada Arzneimittel AG Latest Developments
11.18 AbbVie
11.18.1 AbbVie Company Information
11.18.2 AbbVie Bio Similars/Subsequent Entry Biologic Product Offered
11.18.3 AbbVie Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2020-2022)
11.18.4 AbbVie Main Business Overview
11.18.5 AbbVie Latest Developments
11.19 Sanofi-Aventis
11.19.1 Sanofi-Aventis Company Information
11.19.2 Sanofi-Aventis Bio Similars/Subsequent Entry Biologic Product Offered
11.19.3 Sanofi-Aventis Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2020-2022)
11.19.4 Sanofi-Aventis Main Business Overview
11.19.5 Sanofi-Aventis Latest Developments
11.20 Johnson & Johnson
11.20.1 Johnson & Johnson Company Information
11.20.2 Johnson & Johnson Bio Similars/Subsequent Entry Biologic Product Offered
11.20.3 Johnson & Johnson Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2020-2022)
11.20.4 Johnson & Johnson Main Business Overview
11.20.5 Johnson & Johnson Latest Developments
11.21 Novo Nordisk
11.21.1 Novo Nordisk Company Information
11.21.2 Novo Nordisk Bio Similars/Subsequent Entry Biologic Product Offered
11.21.3 Novo Nordisk Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2020-2022)
11.21.4 Novo Nordisk Main Business Overview
11.21.5 Novo Nordisk Latest Developments
11.22 Eli Lilly
11.22.1 Eli Lilly Company Information
11.22.2 Eli Lilly Bio Similars/Subsequent Entry Biologic Product Offered
11.22.3 Eli Lilly Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2020-2022)
11.22.4 Eli Lilly Main Business Overview
11.22.5 Eli Lilly Latest Developments
11.23 Novartis
11.23.1 Novartis Company Information
11.23.2 Novartis Bio Similars/Subsequent Entry Biologic Product Offered
11.23.3 Novartis Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2020-2022)
11.23.4 Novartis Main Business Overview
11.23.5 Novartis Latest Developments
11.24 3sbio
11.24.1 3sbio Company Information
11.24.2 3sbio Bio Similars/Subsequent Entry Biologic Product Offered
11.24.3 3sbio Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2020-2022)
11.24.4 3sbio Main Business Overview
11.24.5 3sbio Latest Developments
11.25 Biotech
11.25.1 Biotech Company Information
11.25.2 Biotech Bio Similars/Subsequent Entry Biologic Product Offered
11.25.3 Biotech Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2020-2022)
11.25.4 Biotech Main Business Overview
11.25.5 Biotech Latest Developments
11.26 Gelgen
11.26.1 Gelgen Company Information
11.26.2 Gelgen Bio Similars/Subsequent Entry Biologic Product Offered
11.26.3 Gelgen Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2020-2022)
11.26.4 Gelgen Main Business Overview
11.26.5 Gelgen Latest Developments
11.27 Innovent
11.27.1 Innovent Company Information
11.27.2 Innovent Bio Similars/Subsequent Entry Biologic Product Offered
11.27.3 Innovent Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2020-2022)
11.27.4 Innovent Main Business Overview
11.27.5 Innovent Latest Developments
11.28 Dong Bao
11.28.1 Dong Bao Company Information
11.28.2 Dong Bao Bio Similars/Subsequent Entry Biologic Product Offered
11.28.3 Dong Bao Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2020-2022)
11.28.4 Dong Bao Main Business Overview
11.28.5 Dong Bao Latest Developments
11.29 Ganlee
11.29.1 Ganlee Company Information
11.29.2 Ganlee Bio Similars/Subsequent Entry Biologic Product Offered
11.29.3 Ganlee Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2020-2022)
11.29.4 Ganlee Main Business Overview
11.29.5 Ganlee Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Bio Similars/Subsequent Entry Biologic Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Monoclonal Antibodies
Table 3. Major Players of Interferon
Table 4. Major Players of Erythropoietin
Table 5. Major Players of Insulin
Table 6. Major Players of Vaccines
Table 7. Major Players of Other
Table 8. Bio Similars/Subsequent Entry Biologic Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 9. Global Bio Similars/Subsequent Entry Biologic Market Size by Type (2017-2022) & ($ Millions)
Table 10. Global Bio Similars/Subsequent Entry Biologic Market Size Market Share by Type (2017-2022)
Table 11. Bio Similars/Subsequent Entry Biologic Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 12. Global Bio Similars/Subsequent Entry Biologic Market Size by Application (2017-2022) & ($ Millions)
Table 13. Global Bio Similars/Subsequent Entry Biologic Market Size Market Share by Application (2017-2022)
Table 14. Global Bio Similars/Subsequent Entry Biologic Revenue by Players (2020-2022) & ($ Millions)
Table 15. Global Bio Similars/Subsequent Entry Biologic Revenue Market Share by Player (2020-2022)
Table 16. Bio Similars/Subsequent Entry Biologic Key Players Head office and Products Offered
Table 17. Bio Similars/Subsequent Entry Biologic Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 18. New Products and Potential Entrants
Table 19. Mergers & Acquisitions, Expansion
Table 20. Global Bio Similars/Subsequent Entry Biologic Market Size by Regions 2017-2022 & ($ Millions)
Table 21. Global Bio Similars/Subsequent Entry Biologic Market Size Market Share by Regions (2017-2022)
Table 22. Americas Bio Similars/Subsequent Entry Biologic Market Size by Country (2017-2022) & ($ Millions)
Table 23. Americas Bio Similars/Subsequent Entry Biologic Market Size Market Share by Country (2017-2022)
Table 24. Americas Bio Similars/Subsequent Entry Biologic Market Size by Type (2017-2022) & ($ Millions)
Table 25. Americas Bio Similars/Subsequent Entry Biologic Market Size Market Share by Type (2017-2022)
Table 26. Americas Bio Similars/Subsequent Entry Biologic Market Size by Application (2017-2022) & ($ Millions)
Table 27. Americas Bio Similars/Subsequent Entry Biologic Market Size Market Share by Application (2017-2022)
Table 28. APAC Bio Similars/Subsequent Entry Biologic Market Size by Region (2017-2022) & ($ Millions)
Table 29. APAC Bio Similars/Subsequent Entry Biologic Market Size Market Share by Region (2017-2022)
Table 30. APAC Bio Similars/Subsequent Entry Biologic Market Size by Type (2017-2022) & ($ Millions)
Table 31. APAC Bio Similars/Subsequent Entry Biologic Market Size Market Share by Type (2017-2022)
Table 32. APAC Bio Similars/Subsequent Entry Biologic Market Size by Application (2017-2022) & ($ Millions)
Table 33. APAC Bio Similars/Subsequent Entry Biologic Market Size Market Share by Application (2017-2022)
Table 34. Europe Bio Similars/Subsequent Entry Biologic Market Size by Country (2017-2022) & ($ Millions)
Table 35. Europe Bio Similars/Subsequent Entry Biologic Market Size Market Share by Country (2017-2022)
Table 36. Europe Bio Similars/Subsequent Entry Biologic Market Size by Type (2017-2022) & ($ Millions)
Table 37. Europe Bio Similars/Subsequent Entry Biologic Market Size Market Share by Type (2017-2022)
Table 38. Europe Bio Similars/Subsequent Entry Biologic Market Size by Application (2017-2022) & ($ Millions)
Table 39. Europe Bio Similars/Subsequent Entry Biologic Market Size Market Share by Application (2017-2022)
Table 40. Middle East & Africa Bio Similars/Subsequent Entry Biologic Market Size by Region (2017-2022) & ($ Millions)
Table 41. Middle East & Africa Bio Similars/Subsequent Entry Biologic Market Size Market Share by Region (2017-2022)
Table 42. Middle East & Africa Bio Similars/Subsequent Entry Biologic Market Size by Type (2017-2022) & ($ Millions)
Table 43. Middle East & Africa Bio Similars/Subsequent Entry Biologic Market Size Market Share by Type (2017-2022)
Table 44. Middle East & Africa Bio Similars/Subsequent Entry Biologic Market Size by Application (2017-2022) & ($ Millions)
Table 45. Middle East & Africa Bio Similars/Subsequent Entry Biologic Market Size Market Share by Application (2017-2022)
Table 46. Key Market Drivers & Growth Opportunities of Bio Similars/Subsequent Entry Biologic
Table 47. Key Market Challenges & Risks of Bio Similars/Subsequent Entry Biologic
Table 48. Key Industry Trends of Bio Similars/Subsequent Entry Biologic
Table 49. Global Bio Similars/Subsequent Entry Biologic Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 50. Global Bio Similars/Subsequent Entry Biologic Market Size Market Share Forecast by Regions (2023-2028)
Table 51. Global Bio Similars/Subsequent Entry Biologic Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 52. Global Bio Similars/Subsequent Entry Biologic Market Size Market Share Forecast by Type (2023-2028)
Table 53. Global Bio Similars/Subsequent Entry Biologic Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 54. Global Bio Similars/Subsequent Entry Biologic Market Size Market Share Forecast by Application (2023-2028)
Table 55. Sun Pharma Details, Company Type, Bio Similars/Subsequent Entry Biologic Area Served and Its Competitors
Table 56. Sun Pharma Bio Similars/Subsequent Entry Biologic Product Offered
Table 57. Sun Pharma Bio Similars/Subsequent Entry Biologic Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 58. Sun Pharma Main Business
Table 59. Sun Pharma Latest Developments
Table 60. Synthon Pharmaceuticals Details, Company Type, Bio Similars/Subsequent Entry Biologic Area Served and Its Competitors
Table 61. Synthon Pharmaceuticals Bio Similars/Subsequent Entry Biologic Product Offered
Table 62. Synthon Pharmaceuticals Main Business
Table 63. Synthon Pharmaceuticals Bio Similars/Subsequent Entry Biologic Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 64. Synthon Pharmaceuticals Latest Developments
Table 65. Teva Pharmaceutical Industries Details, Company Type, Bio Similars/Subsequent Entry Biologic Area Served and Its Competitors
Table 66. Teva Pharmaceutical Industries Bio Similars/Subsequent Entry Biologic Product Offered
Table 67. Teva Pharmaceutical Industries Main Business
Table 68. Teva Pharmaceutical Industries Bio Similars/Subsequent Entry Biologic Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 69. Teva Pharmaceutical Industries Latest Developments
Table 70. LG Life Sciences Details, Company Type, Bio Similars/Subsequent Entry Biologic Area Served and Its Competitors
Table 71. LG Life Sciences Bio Similars/Subsequent Entry Biologic Product Offered
Table 72. LG Life Sciences Main Business
Table 73. LG Life Sciences Bio Similars/Subsequent Entry Biologic Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 74. LG Life Sciences Latest Developments
Table 75. Celltrion Biocon Details, Company Type, Bio Similars/Subsequent Entry Biologic Area Served and Its Competitors
Table 76. Celltrion Biocon Bio Similars/Subsequent Entry Biologic Product Offered
Table 77. Celltrion Biocon Main Business
Table 78. Celltrion Biocon Bio Similars/Subsequent Entry Biologic Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 79. Celltrion Biocon Latest Developments
Table 80. Hospira Details, Company Type, Bio Similars/Subsequent Entry Biologic Area Served and Its Competitors
Table 81. Hospira Bio Similars/Subsequent Entry Biologic Product Offered
Table 82. Hospira Main Business
Table 83. Hospira Bio Similars/Subsequent Entry Biologic Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 84. Hospira Latest Developments
Table 85. Merck Details, Company Type, Bio Similars/Subsequent Entry Biologic Area Served and Its Competitors
Table 86. Merck Bio Similars/Subsequent Entry Biologic Product Offered
Table 87. Merck Main Business
Table 88. Merck Bio Similars/Subsequent Entry Biologic Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 89. Merck Latest Developments
Table 90. Biogen idec Details, Company Type, Bio Similars/Subsequent Entry Biologic Area Served and Its Competitors
Table 91. Biogen idec Bio Similars/Subsequent Entry Biologic Product Offered
Table 92. Biogen idec Main Business
Table 93. Biogen idec Bio Similars/Subsequent Entry Biologic Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 94. Biogen idec Latest Developments
Table 95. Genentech (Roche) Details, Company Type, Bio Similars/Subsequent Entry Biologic Area Served and Its Competitors
Table 96. Genentech (Roche) Bio Similars/Subsequent Entry Biologic Product Offered
Table 97. Genentech (Roche) Main Business
Table 98. Genentech (Roche) Bio Similars/Subsequent Entry Biologic Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 99. Genentech (Roche) Latest Developments
Table 100. Pfizer Details, Company Type, Bio Similars/Subsequent Entry Biologic Area Served and Its Competitors
Table 101. Pfizer Bio Similars/Subsequent Entry Biologic Product Offered
Table 102. Pfizer Main Business
Table 103. Pfizer Bio Similars/Subsequent Entry Biologic Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 104. Pfizer Latest Developments
Table 105. Celltrion Details, Company Type, Bio Similars/Subsequent Entry Biologic Area Served and Its Competitors
Table 106. Celltrion Bio Similars/Subsequent Entry Biologic Product Offered
Table 107. Celltrion Bio Similars/Subsequent Entry Biologic Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 108. Celltrion Main Business
Table 109. Celltrion Latest Developments
Table 110. Biocon Details, Company Type, Bio Similars/Subsequent Entry Biologic Area Served and Its Competitors
Table 111. Biocon Bio Similars/Subsequent Entry Biologic Product Offered
Table 112. Biocon Main Business
Table 113. Biocon Bio Similars/Subsequent Entry Biologic Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 114. Biocon Latest Developments
Table 115. Amgen Details, Company Type, Bio Similars/Subsequent Entry Biologic Area Served and Its Competitors
Table 116. Amgen Bio Similars/Subsequent Entry Biologic Product Offered
Table 117. Amgen Main Business
Table 118. Amgen Bio Similars/Subsequent Entry Biologic Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 119. Amgen Latest Developments
Table 120. Samsung Biologics Details, Company Type, Bio Similars/Subsequent Entry Biologic Area Served and Its Competitors
Table 121. Samsung Biologics Bio Similars/Subsequent Entry Biologic Product Offered
Table 122. Samsung Biologics Main Business
Table 123. Samsung Biologics Bio Similars/Subsequent Entry Biologic Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 124. Samsung Biologics Latest Developments
Table 125. Mylan Details, Company Type, Bio Similars/Subsequent Entry Biologic Area Served and Its Competitors
Table 126. Mylan Bio Similars/Subsequent Entry Biologic Product Offered
Table 127. Mylan Main Business
Table 128. Mylan Bio Similars/Subsequent Entry Biologic Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 129. Mylan Latest Developments
Table 130. Dr. Reddy's Laboratories Details, Company Type, Bio Similars/Subsequent Entry Biologic Area Served and Its Competitors
Table 131. Dr. Reddy's Laboratories Bio Similars/Subsequent Entry Biologic Product Offered
Table 132. Dr. Reddy's Laboratories Main Business
Table 133. Dr. Reddy's Laboratories Bio Similars/Subsequent Entry Biologic Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 134. Dr. Reddy's Laboratories Latest Developments
Table 135. Stada Arzneimittel AG Details, Company Type, Bio Similars/Subsequent Entry Biologic Area Served and Its Competitors
Table 136. Stada Arzneimittel AG Bio Similars/Subsequent Entry Biologic Product Offered
Table 137. Stada Arzneimittel AG Main Business
Table 138. Stada Arzneimittel AG Bio Similars/Subsequent Entry Biologic Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 139. Stada Arzneimittel AG Latest Developments
Table 140. AbbVie Details, Company Type, Bio Similars/Subsequent Entry Biologic Area Served and Its Competitors
Table 141. AbbVie Bio Similars/Subsequent Entry Biologic Product Offered
Table 142. AbbVie Main Business
Table 143. AbbVie Bio Similars/Subsequent Entry Biologic Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 144. AbbVie Latest Developments
Table 145. Sanofi-Aventis Details, Company Type, Bio Similars/Subsequent Entry Biologic Area Served and Its Competitors
Table 146. Sanofi-Aventis Bio Similars/Subsequent Entry Biologic Product Offered
Table 147. Sanofi-Aventis Main Business
Table 148. Sanofi-Aventis Bio Similars/Subsequent Entry Biologic Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 149. Sanofi-Aventis Latest Developments
Table 150. Johnson & Johnson Details, Company Type, Bio Similars/Subsequent Entry Biologic Area Served and Its Competitors
Table 151. Johnson & Johnson Bio Similars/Subsequent Entry Biologic Product Offered
Table 152. Johnson & Johnson Main Business
Table 153. Johnson & Johnson Bio Similars/Subsequent Entry Biologic Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 154. Johnson & Johnson Latest Developments
Table 155. Novo Nordisk Details, Company Type, Bio Similars/Subsequent Entry Biologic Area Served and Its Competitors
Table 156. Novo Nordisk Bio Similars/Subsequent Entry Biologic Product Offered
Table 157. Novo Nordisk Bio Similars/Subsequent Entry Biologic Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 158. Novo Nordisk Main Business
Table 159. Novo Nordisk Latest Developments
Table 160. Eli Lilly Details, Company Type, Bio Similars/Subsequent Entry Biologic Area Served and Its Competitors
Table 161. Eli Lilly Bio Similars/Subsequent Entry Biologic Product Offered
Table 162. Eli Lilly Main Business
Table 163. Eli Lilly Bio Similars/Subsequent Entry Biologic Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 164. Eli Lilly Latest Developments
Table 165. Novartis Details, Company Type, Bio Similars/Subsequent Entry Biologic Area Served and Its Competitors
Table 166. Novartis Bio Similars/Subsequent Entry Biologic Product Offered
Table 167. Novartis Main Business
Table 168. Novartis Bio Similars/Subsequent Entry Biologic Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 169. Novartis Latest Developments
Table 170. 3sbio Details, Company Type, Bio Similars/Subsequent Entry Biologic Area Served and Its Competitors
Table 171. 3sbio Bio Similars/Subsequent Entry Biologic Product Offered
Table 172. 3sbio Main Business
Table 173. 3sbio Bio Similars/Subsequent Entry Biologic Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 174. 3sbio Latest Developments
Table 175. Biotech Details, Company Type, Bio Similars/Subsequent Entry Biologic Area Served and Its Competitors
Table 176. Biotech Bio Similars/Subsequent Entry Biologic Product Offered
Table 177. Biotech Main Business
Table 178. Biotech Bio Similars/Subsequent Entry Biologic Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 179. Biotech Latest Developments
Table 180. Gelgen Details, Company Type, Bio Similars/Subsequent Entry Biologic Area Served and Its Competitors
Table 181. Gelgen Bio Similars/Subsequent Entry Biologic Product Offered
Table 182. Gelgen Main Business
Table 183. Gelgen Bio Similars/Subsequent Entry Biologic Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 184. Gelgen Latest Developments
Table 185. Innovent Details, Company Type, Bio Similars/Subsequent Entry Biologic Area Served and Its Competitors
Table 186. Innovent Bio Similars/Subsequent Entry Biologic Product Offered
Table 187. Innovent Main Business
Table 188. Innovent Bio Similars/Subsequent Entry Biologic Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 189. Innovent Latest Developments
Table 190. Dong Bao Details, Company Type, Bio Similars/Subsequent Entry Biologic Area Served and Its Competitors
Table 191. Dong Bao Bio Similars/Subsequent Entry Biologic Product Offered
Table 192. Dong Bao Main Business
Table 193. Dong Bao Bio Similars/Subsequent Entry Biologic Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 194. Dong Bao Latest Developments
Table 195. Ganlee Details, Company Type, Bio Similars/Subsequent Entry Biologic Area Served and Its Competitors
Table 196. Ganlee Bio Similars/Subsequent Entry Biologic Product Offered
Table 197. Ganlee Main Business
Table 198. Ganlee Bio Similars/Subsequent Entry Biologic Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 199. Ganlee Latest Developments
Table 1. Bio Similars/Subsequent Entry Biologic Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Monoclonal Antibodies
Table 3. Major Players of Interferon
Table 4. Major Players of Erythropoietin
Table 5. Major Players of Insulin
Table 6. Major Players of Vaccines
Table 7. Major Players of Other
Table 8. Bio Similars/Subsequent Entry Biologic Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 9. Global Bio Similars/Subsequent Entry Biologic Market Size by Type (2017-2022) & ($ Millions)
Table 10. Global Bio Similars/Subsequent Entry Biologic Market Size Market Share by Type (2017-2022)
Table 11. Bio Similars/Subsequent Entry Biologic Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 12. Global Bio Similars/Subsequent Entry Biologic Market Size by Application (2017-2022) & ($ Millions)
Table 13. Global Bio Similars/Subsequent Entry Biologic Market Size Market Share by Application (2017-2022)
Table 14. Global Bio Similars/Subsequent Entry Biologic Revenue by Players (2020-2022) & ($ Millions)
Table 15. Global Bio Similars/Subsequent Entry Biologic Revenue Market Share by Player (2020-2022)
Table 16. Bio Similars/Subsequent Entry Biologic Key Players Head office and Products Offered
Table 17. Bio Similars/Subsequent Entry Biologic Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 18. New Products and Potential Entrants
Table 19. Mergers & Acquisitions, Expansion
Table 20. Global Bio Similars/Subsequent Entry Biologic Market Size by Regions 2017-2022 & ($ Millions)
Table 21. Global Bio Similars/Subsequent Entry Biologic Market Size Market Share by Regions (2017-2022)
Table 22. Americas Bio Similars/Subsequent Entry Biologic Market Size by Country (2017-2022) & ($ Millions)
Table 23. Americas Bio Similars/Subsequent Entry Biologic Market Size Market Share by Country (2017-2022)
Table 24. Americas Bio Similars/Subsequent Entry Biologic Market Size by Type (2017-2022) & ($ Millions)
Table 25. Americas Bio Similars/Subsequent Entry Biologic Market Size Market Share by Type (2017-2022)
Table 26. Americas Bio Similars/Subsequent Entry Biologic Market Size by Application (2017-2022) & ($ Millions)
Table 27. Americas Bio Similars/Subsequent Entry Biologic Market Size Market Share by Application (2017-2022)
Table 28. APAC Bio Similars/Subsequent Entry Biologic Market Size by Region (2017-2022) & ($ Millions)
Table 29. APAC Bio Similars/Subsequent Entry Biologic Market Size Market Share by Region (2017-2022)
Table 30. APAC Bio Similars/Subsequent Entry Biologic Market Size by Type (2017-2022) & ($ Millions)
Table 31. APAC Bio Similars/Subsequent Entry Biologic Market Size Market Share by Type (2017-2022)
Table 32. APAC Bio Similars/Subsequent Entry Biologic Market Size by Application (2017-2022) & ($ Millions)
Table 33. APAC Bio Similars/Subsequent Entry Biologic Market Size Market Share by Application (2017-2022)
Table 34. Europe Bio Similars/Subsequent Entry Biologic Market Size by Country (2017-2022) & ($ Millions)
Table 35. Europe Bio Similars/Subsequent Entry Biologic Market Size Market Share by Country (2017-2022)
Table 36. Europe Bio Similars/Subsequent Entry Biologic Market Size by Type (2017-2022) & ($ Millions)
Table 37. Europe Bio Similars/Subsequent Entry Biologic Market Size Market Share by Type (2017-2022)
Table 38. Europe Bio Similars/Subsequent Entry Biologic Market Size by Application (2017-2022) & ($ Millions)
Table 39. Europe Bio Similars/Subsequent Entry Biologic Market Size Market Share by Application (2017-2022)
Table 40. Middle East & Africa Bio Similars/Subsequent Entry Biologic Market Size by Region (2017-2022) & ($ Millions)
Table 41. Middle East & Africa Bio Similars/Subsequent Entry Biologic Market Size Market Share by Region (2017-2022)
Table 42. Middle East & Africa Bio Similars/Subsequent Entry Biologic Market Size by Type (2017-2022) & ($ Millions)
Table 43. Middle East & Africa Bio Similars/Subsequent Entry Biologic Market Size Market Share by Type (2017-2022)
Table 44. Middle East & Africa Bio Similars/Subsequent Entry Biologic Market Size by Application (2017-2022) & ($ Millions)
Table 45. Middle East & Africa Bio Similars/Subsequent Entry Biologic Market Size Market Share by Application (2017-2022)
Table 46. Key Market Drivers & Growth Opportunities of Bio Similars/Subsequent Entry Biologic
Table 47. Key Market Challenges & Risks of Bio Similars/Subsequent Entry Biologic
Table 48. Key Industry Trends of Bio Similars/Subsequent Entry Biologic
Table 49. Global Bio Similars/Subsequent Entry Biologic Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 50. Global Bio Similars/Subsequent Entry Biologic Market Size Market Share Forecast by Regions (2023-2028)
Table 51. Global Bio Similars/Subsequent Entry Biologic Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 52. Global Bio Similars/Subsequent Entry Biologic Market Size Market Share Forecast by Type (2023-2028)
Table 53. Global Bio Similars/Subsequent Entry Biologic Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 54. Global Bio Similars/Subsequent Entry Biologic Market Size Market Share Forecast by Application (2023-2028)
Table 55. Sun Pharma Details, Company Type, Bio Similars/Subsequent Entry Biologic Area Served and Its Competitors
Table 56. Sun Pharma Bio Similars/Subsequent Entry Biologic Product Offered
Table 57. Sun Pharma Bio Similars/Subsequent Entry Biologic Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 58. Sun Pharma Main Business
Table 59. Sun Pharma Latest Developments
Table 60. Synthon Pharmaceuticals Details, Company Type, Bio Similars/Subsequent Entry Biologic Area Served and Its Competitors
Table 61. Synthon Pharmaceuticals Bio Similars/Subsequent Entry Biologic Product Offered
Table 62. Synthon Pharmaceuticals Main Business
Table 63. Synthon Pharmaceuticals Bio Similars/Subsequent Entry Biologic Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 64. Synthon Pharmaceuticals Latest Developments
Table 65. Teva Pharmaceutical Industries Details, Company Type, Bio Similars/Subsequent Entry Biologic Area Served and Its Competitors
Table 66. Teva Pharmaceutical Industries Bio Similars/Subsequent Entry Biologic Product Offered
Table 67. Teva Pharmaceutical Industries Main Business
Table 68. Teva Pharmaceutical Industries Bio Similars/Subsequent Entry Biologic Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 69. Teva Pharmaceutical Industries Latest Developments
Table 70. LG Life Sciences Details, Company Type, Bio Similars/Subsequent Entry Biologic Area Served and Its Competitors
Table 71. LG Life Sciences Bio Similars/Subsequent Entry Biologic Product Offered
Table 72. LG Life Sciences Main Business
Table 73. LG Life Sciences Bio Similars/Subsequent Entry Biologic Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 74. LG Life Sciences Latest Developments
Table 75. Celltrion Biocon Details, Company Type, Bio Similars/Subsequent Entry Biologic Area Served and Its Competitors
Table 76. Celltrion Biocon Bio Similars/Subsequent Entry Biologic Product Offered
Table 77. Celltrion Biocon Main Business
Table 78. Celltrion Biocon Bio Similars/Subsequent Entry Biologic Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 79. Celltrion Biocon Latest Developments
Table 80. Hospira Details, Company Type, Bio Similars/Subsequent Entry Biologic Area Served and Its Competitors
Table 81. Hospira Bio Similars/Subsequent Entry Biologic Product Offered
Table 82. Hospira Main Business
Table 83. Hospira Bio Similars/Subsequent Entry Biologic Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 84. Hospira Latest Developments
Table 85. Merck Details, Company Type, Bio Similars/Subsequent Entry Biologic Area Served and Its Competitors
Table 86. Merck Bio Similars/Subsequent Entry Biologic Product Offered
Table 87. Merck Main Business
Table 88. Merck Bio Similars/Subsequent Entry Biologic Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 89. Merck Latest Developments
Table 90. Biogen idec Details, Company Type, Bio Similars/Subsequent Entry Biologic Area Served and Its Competitors
Table 91. Biogen idec Bio Similars/Subsequent Entry Biologic Product Offered
Table 92. Biogen idec Main Business
Table 93. Biogen idec Bio Similars/Subsequent Entry Biologic Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 94. Biogen idec Latest Developments
Table 95. Genentech (Roche) Details, Company Type, Bio Similars/Subsequent Entry Biologic Area Served and Its Competitors
Table 96. Genentech (Roche) Bio Similars/Subsequent Entry Biologic Product Offered
Table 97. Genentech (Roche) Main Business
Table 98. Genentech (Roche) Bio Similars/Subsequent Entry Biologic Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 99. Genentech (Roche) Latest Developments
Table 100. Pfizer Details, Company Type, Bio Similars/Subsequent Entry Biologic Area Served and Its Competitors
Table 101. Pfizer Bio Similars/Subsequent Entry Biologic Product Offered
Table 102. Pfizer Main Business
Table 103. Pfizer Bio Similars/Subsequent Entry Biologic Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 104. Pfizer Latest Developments
Table 105. Celltrion Details, Company Type, Bio Similars/Subsequent Entry Biologic Area Served and Its Competitors
Table 106. Celltrion Bio Similars/Subsequent Entry Biologic Product Offered
Table 107. Celltrion Bio Similars/Subsequent Entry Biologic Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 108. Celltrion Main Business
Table 109. Celltrion Latest Developments
Table 110. Biocon Details, Company Type, Bio Similars/Subsequent Entry Biologic Area Served and Its Competitors
Table 111. Biocon Bio Similars/Subsequent Entry Biologic Product Offered
Table 112. Biocon Main Business
Table 113. Biocon Bio Similars/Subsequent Entry Biologic Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 114. Biocon Latest Developments
Table 115. Amgen Details, Company Type, Bio Similars/Subsequent Entry Biologic Area Served and Its Competitors
Table 116. Amgen Bio Similars/Subsequent Entry Biologic Product Offered
Table 117. Amgen Main Business
Table 118. Amgen Bio Similars/Subsequent Entry Biologic Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 119. Amgen Latest Developments
Table 120. Samsung Biologics Details, Company Type, Bio Similars/Subsequent Entry Biologic Area Served and Its Competitors
Table 121. Samsung Biologics Bio Similars/Subsequent Entry Biologic Product Offered
Table 122. Samsung Biologics Main Business
Table 123. Samsung Biologics Bio Similars/Subsequent Entry Biologic Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 124. Samsung Biologics Latest Developments
Table 125. Mylan Details, Company Type, Bio Similars/Subsequent Entry Biologic Area Served and Its Competitors
Table 126. Mylan Bio Similars/Subsequent Entry Biologic Product Offered
Table 127. Mylan Main Business
Table 128. Mylan Bio Similars/Subsequent Entry Biologic Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 129. Mylan Latest Developments
Table 130. Dr. Reddy's Laboratories Details, Company Type, Bio Similars/Subsequent Entry Biologic Area Served and Its Competitors
Table 131. Dr. Reddy's Laboratories Bio Similars/Subsequent Entry Biologic Product Offered
Table 132. Dr. Reddy's Laboratories Main Business
Table 133. Dr. Reddy's Laboratories Bio Similars/Subsequent Entry Biologic Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 134. Dr. Reddy's Laboratories Latest Developments
Table 135. Stada Arzneimittel AG Details, Company Type, Bio Similars/Subsequent Entry Biologic Area Served and Its Competitors
Table 136. Stada Arzneimittel AG Bio Similars/Subsequent Entry Biologic Product Offered
Table 137. Stada Arzneimittel AG Main Business
Table 138. Stada Arzneimittel AG Bio Similars/Subsequent Entry Biologic Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 139. Stada Arzneimittel AG Latest Developments
Table 140. AbbVie Details, Company Type, Bio Similars/Subsequent Entry Biologic Area Served and Its Competitors
Table 141. AbbVie Bio Similars/Subsequent Entry Biologic Product Offered
Table 142. AbbVie Main Business
Table 143. AbbVie Bio Similars/Subsequent Entry Biologic Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 144. AbbVie Latest Developments
Table 145. Sanofi-Aventis Details, Company Type, Bio Similars/Subsequent Entry Biologic Area Served and Its Competitors
Table 146. Sanofi-Aventis Bio Similars/Subsequent Entry Biologic Product Offered
Table 147. Sanofi-Aventis Main Business
Table 148. Sanofi-Aventis Bio Similars/Subsequent Entry Biologic Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 149. Sanofi-Aventis Latest Developments
Table 150. Johnson & Johnson Details, Company Type, Bio Similars/Subsequent Entry Biologic Area Served and Its Competitors
Table 151. Johnson & Johnson Bio Similars/Subsequent Entry Biologic Product Offered
Table 152. Johnson & Johnson Main Business
Table 153. Johnson & Johnson Bio Similars/Subsequent Entry Biologic Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 154. Johnson & Johnson Latest Developments
Table 155. Novo Nordisk Details, Company Type, Bio Similars/Subsequent Entry Biologic Area Served and Its Competitors
Table 156. Novo Nordisk Bio Similars/Subsequent Entry Biologic Product Offered
Table 157. Novo Nordisk Bio Similars/Subsequent Entry Biologic Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 158. Novo Nordisk Main Business
Table 159. Novo Nordisk Latest Developments
Table 160. Eli Lilly Details, Company Type, Bio Similars/Subsequent Entry Biologic Area Served and Its Competitors
Table 161. Eli Lilly Bio Similars/Subsequent Entry Biologic Product Offered
Table 162. Eli Lilly Main Business
Table 163. Eli Lilly Bio Similars/Subsequent Entry Biologic Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 164. Eli Lilly Latest Developments
Table 165. Novartis Details, Company Type, Bio Similars/Subsequent Entry Biologic Area Served and Its Competitors
Table 166. Novartis Bio Similars/Subsequent Entry Biologic Product Offered
Table 167. Novartis Main Business
Table 168. Novartis Bio Similars/Subsequent Entry Biologic Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 169. Novartis Latest Developments
Table 170. 3sbio Details, Company Type, Bio Similars/Subsequent Entry Biologic Area Served and Its Competitors
Table 171. 3sbio Bio Similars/Subsequent Entry Biologic Product Offered
Table 172. 3sbio Main Business
Table 173. 3sbio Bio Similars/Subsequent Entry Biologic Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 174. 3sbio Latest Developments
Table 175. Biotech Details, Company Type, Bio Similars/Subsequent Entry Biologic Area Served and Its Competitors
Table 176. Biotech Bio Similars/Subsequent Entry Biologic Product Offered
Table 177. Biotech Main Business
Table 178. Biotech Bio Similars/Subsequent Entry Biologic Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 179. Biotech Latest Developments
Table 180. Gelgen Details, Company Type, Bio Similars/Subsequent Entry Biologic Area Served and Its Competitors
Table 181. Gelgen Bio Similars/Subsequent Entry Biologic Product Offered
Table 182. Gelgen Main Business
Table 183. Gelgen Bio Similars/Subsequent Entry Biologic Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 184. Gelgen Latest Developments
Table 185. Innovent Details, Company Type, Bio Similars/Subsequent Entry Biologic Area Served and Its Competitors
Table 186. Innovent Bio Similars/Subsequent Entry Biologic Product Offered
Table 187. Innovent Main Business
Table 188. Innovent Bio Similars/Subsequent Entry Biologic Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 189. Innovent Latest Developments
Table 190. Dong Bao Details, Company Type, Bio Similars/Subsequent Entry Biologic Area Served and Its Competitors
Table 191. Dong Bao Bio Similars/Subsequent Entry Biologic Product Offered
Table 192. Dong Bao Main Business
Table 193. Dong Bao Bio Similars/Subsequent Entry Biologic Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 194. Dong Bao Latest Developments
Table 195. Ganlee Details, Company Type, Bio Similars/Subsequent Entry Biologic Area Served and Its Competitors
Table 196. Ganlee Bio Similars/Subsequent Entry Biologic Product Offered
Table 197. Ganlee Main Business
Table 198. Ganlee Bio Similars/Subsequent Entry Biologic Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 199. Ganlee Latest Developments
LIST OF FIGURES
Figure 1. Bio Similars/Subsequent Entry Biologic Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Bio Similars/Subsequent Entry Biologic Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Bio Similars/Subsequent Entry Biologic Market Size Market Share by Type in 2021
Figure 7. Bio Similars/Subsequent Entry Biologic in Tumor
Figure 8. Global Bio Similars/Subsequent Entry Biologic Market: Tumor (2017-2022) & ($ Millions)
Figure 9. Bio Similars/Subsequent Entry Biologic in Diabetes
Figure 10. Global Bio Similars/Subsequent Entry Biologic Market: Diabetes (2017-2022) & ($ Millions)
Figure 11. Bio Similars/Subsequent Entry Biologic in Cardiovascular
Figure 12. Global Bio Similars/Subsequent Entry Biologic Market: Cardiovascular (2017-2022) & ($ Millions)
Figure 13. Bio Similars/Subsequent Entry Biologic in Hemophilia
Figure 14. Global Bio Similars/Subsequent Entry Biologic Market: Hemophilia (2017-2022) & ($ Millions)
Figure 15. Bio Similars/Subsequent Entry Biologic in Other
Figure 16. Global Bio Similars/Subsequent Entry Biologic Market: Other (2017-2022) & ($ Millions)
Figure 17. Global Bio Similars/Subsequent Entry Biologic Market Size Market Share by Application in 2021
Figure 18. Global Bio Similars/Subsequent Entry Biologic Revenue Market Share by Player in 2021
Figure 19. Global Bio Similars/Subsequent Entry Biologic Market Size Market Share by Regions (2017-2022)
Figure 20. Americas Bio Similars/Subsequent Entry Biologic Market Size 2017-2022 ($ Millions)
Figure 21. APAC Bio Similars/Subsequent Entry Biologic Market Size 2017-2022 ($ Millions)
Figure 22. Europe Bio Similars/Subsequent Entry Biologic Market Size 2017-2022 ($ Millions)
Figure 23. Middle East & Africa Bio Similars/Subsequent Entry Biologic Market Size 2017-2022 ($ Millions)
Figure 24. Americas Bio Similars/Subsequent Entry Biologic Value Market Share by Country in 2021
Figure 25. Americas Bio Similars/Subsequent Entry Biologic Consumption Market Share by Type in 2021
Figure 26. Americas Bio Similars/Subsequent Entry Biologic Market Size Market Share by Application in 2021
Figure 27. United States Bio Similars/Subsequent Entry Biologic Market Size Growth 2017-2022 ($ Millions)
Figure 28. Canada Bio Similars/Subsequent Entry Biologic Market Size Growth 2017-2022 ($ Millions)
Figure 29. Mexico Bio Similars/Subsequent Entry Biologic Market Size Growth 2017-2022 ($ Millions)
Figure 30. Brazil Bio Similars/Subsequent Entry Biologic Market Size Growth 2017-2022 ($ Millions)
Figure 31. APAC Bio Similars/Subsequent Entry Biologic Market Size Market Share by Region in 2021
Figure 32. APAC Bio Similars/Subsequent Entry Biologic Market Size Market Share by Application in 2021
Figure 33. China Bio Similars/Subsequent Entry Biologic Market Size Growth 2017-2022 ($ Millions)
Figure 34. Japan Bio Similars/Subsequent Entry Biologic Market Size Growth 2017-2022 ($ Millions)
Figure 35. Korea Bio Similars/Subsequent Entry Biologic Market Size Growth 2017-2022 ($ Millions)
Figure 36. Southeast Asia Bio Similars/Subsequent Entry Biologic Market Size Growth 2017-2022 ($ Millions)
Figure 37. India Bio Similars/Subsequent Entry Biologic Market Size Growth 2017-2022 ($ Millions)
Figure 38. Australia Bio Similars/Subsequent Entry Biologic Market Size Growth 2017-2022 ($ Millions)
Figure 39. Europe Bio Similars/Subsequent Entry Biologic Market Size Market Share by Country in 2021
Figure 40. Europe Bio Similars/Subsequent Entry Biologic Market Size Market Share by Type in 2021
Figure 41. Europe Bio Similars/Subsequent Entry Biologic Market Size Market Share by Application in 2021
Figure 42. Germany Bio Similars/Subsequent Entry Biologic Market Size Growth 2017-2022 ($ Millions)
Figure 43. France Bio Similars/Subsequent Entry Biologic Market Size Growth 2017-2022 ($ Millions)
Figure 44. UK Bio Similars/Subsequent Entry Biologic Market Size Growth 2017-2022 ($ Millions)
Figure 45. Italy Bio Similars/Subsequent Entry Biologic Market Size Growth 2017-2022 ($ Millions)
Figure 46. Russia Bio Similars/Subsequent Entry Biologic Market Size Growth 2017-2022 ($ Millions)
Figure 47. Middle East & Africa Bio Similars/Subsequent Entry Biologic Market Size Market Share by Region in 2021
Figure 48. Middle East & Africa Bio Similars/Subsequent Entry Biologic Market Size Market Share by Type in 2021
Figure 49. Middle East & Africa Bio Similars/Subsequent Entry Biologic Market Size Market Share by Application in 2021
Figure 50. Egypt Bio Similars/Subsequent Entry Biologic Market Size Growth 2017-2022 ($ Millions)
Figure 51. South Africa Bio Similars/Subsequent Entry Biologic Market Size Growth 2017-2022 ($ Millions)
Figure 52. Israel Bio Similars/Subsequent Entry Biologic Market Size Growth 2017-2022 ($ Millions)
Figure 53. Turkey Bio Similars/Subsequent Entry Biologic Market Size Growth 2017-2022 ($ Millions)
Figure 54. GCC Country Bio Similars/Subsequent Entry Biologic Market Size Growth 2017-2022 ($ Millions)
Figure 55. Americas Bio Similars/Subsequent Entry Biologic Market Size 2023-2028 ($ Millions)
Figure 56. APAC Bio Similars/Subsequent Entry Biologic Market Size 2023-2028 ($ Millions)
Figure 57. Europe Bio Similars/Subsequent Entry Biologic Market Size 2023-2028 ($ Millions)
Figure 58. Middle East & Africa Bio Similars/Subsequent Entry Biologic Market Size 2023-2028 ($ Millions)
Figure 59. United States Bio Similars/Subsequent Entry Biologic Market Size 2023-2028 ($ Millions)
Figure 60. Canada Bio Similars/Subsequent Entry Biologic Market Size 2023-2028 ($ Millions)
Figure 61. Mexico Bio Similars/Subsequent Entry Biologic Market Size 2023-2028 ($ Millions)
Figure 62. Brazil Bio Similars/Subsequent Entry Biologic Market Size 2023-2028 ($ Millions)
Figure 63. China Bio Similars/Subsequent Entry Biologic Market Size 2023-2028 ($ Millions)
Figure 64. Japan Bio Similars/Subsequent Entry Biologic Market Size 2023-2028 ($ Millions)
Figure 65. Korea Bio Similars/Subsequent Entry Biologic Market Size 2023-2028 ($ Millions)
Figure 66. Southeast Asia Bio Similars/Subsequent Entry Biologic Market Size 2023-2028 ($ Millions)
Figure 67. India Bio Similars/Subsequent Entry Biologic Market Size 2023-2028 ($ Millions)
Figure 68. Australia Bio Similars/Subsequent Entry Biologic Market Size 2023-2028 ($ Millions)
Figure 69. Germany Bio Similars/Subsequent Entry Biologic Market Size 2023-2028 ($ Millions)
Figure 70. France Bio Similars/Subsequent Entry Biologic Market Size 2023-2028 ($ Millions)
Figure 71. UK Bio Similars/Subsequent Entry Biologic Market Size 2023-2028 ($ Millions)
Figure 72. Italy Bio Similars/Subsequent Entry Biologic Market Size 2023-2028 ($ Millions)
Figure 73. Russia Bio Similars/Subsequent Entry Biologic Market Size 2023-2028 ($ Millions)
Figure 74. Spain Bio Similars/Subsequent Entry Biologic Market Size 2023-2028 ($ Millions)
Figure 75. Egypt Bio Similars/Subsequent Entry Biologic Market Size 2023-2028 ($ Millions)
Figure 76. South Africa Bio Similars/Subsequent Entry Biologic Market Size 2023-2028 ($ Millions)
Figure 77. Israel Bio Similars/Subsequent Entry Biologic Market Size 2023-2028 ($ Millions)
Figure 78. Turkey Bio Similars/Subsequent Entry Biologic Market Size 2023-2028 ($ Millions)
Figure 79. GCC Countries Bio Similars/Subsequent Entry Biologic Market Size 2023-2028 ($ Millions)
Figure 1. Bio Similars/Subsequent Entry Biologic Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Bio Similars/Subsequent Entry Biologic Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Bio Similars/Subsequent Entry Biologic Market Size Market Share by Type in 2021
Figure 7. Bio Similars/Subsequent Entry Biologic in Tumor
Figure 8. Global Bio Similars/Subsequent Entry Biologic Market: Tumor (2017-2022) & ($ Millions)
Figure 9. Bio Similars/Subsequent Entry Biologic in Diabetes
Figure 10. Global Bio Similars/Subsequent Entry Biologic Market: Diabetes (2017-2022) & ($ Millions)
Figure 11. Bio Similars/Subsequent Entry Biologic in Cardiovascular
Figure 12. Global Bio Similars/Subsequent Entry Biologic Market: Cardiovascular (2017-2022) & ($ Millions)
Figure 13. Bio Similars/Subsequent Entry Biologic in Hemophilia
Figure 14. Global Bio Similars/Subsequent Entry Biologic Market: Hemophilia (2017-2022) & ($ Millions)
Figure 15. Bio Similars/Subsequent Entry Biologic in Other
Figure 16. Global Bio Similars/Subsequent Entry Biologic Market: Other (2017-2022) & ($ Millions)
Figure 17. Global Bio Similars/Subsequent Entry Biologic Market Size Market Share by Application in 2021
Figure 18. Global Bio Similars/Subsequent Entry Biologic Revenue Market Share by Player in 2021
Figure 19. Global Bio Similars/Subsequent Entry Biologic Market Size Market Share by Regions (2017-2022)
Figure 20. Americas Bio Similars/Subsequent Entry Biologic Market Size 2017-2022 ($ Millions)
Figure 21. APAC Bio Similars/Subsequent Entry Biologic Market Size 2017-2022 ($ Millions)
Figure 22. Europe Bio Similars/Subsequent Entry Biologic Market Size 2017-2022 ($ Millions)
Figure 23. Middle East & Africa Bio Similars/Subsequent Entry Biologic Market Size 2017-2022 ($ Millions)
Figure 24. Americas Bio Similars/Subsequent Entry Biologic Value Market Share by Country in 2021
Figure 25. Americas Bio Similars/Subsequent Entry Biologic Consumption Market Share by Type in 2021
Figure 26. Americas Bio Similars/Subsequent Entry Biologic Market Size Market Share by Application in 2021
Figure 27. United States Bio Similars/Subsequent Entry Biologic Market Size Growth 2017-2022 ($ Millions)
Figure 28. Canada Bio Similars/Subsequent Entry Biologic Market Size Growth 2017-2022 ($ Millions)
Figure 29. Mexico Bio Similars/Subsequent Entry Biologic Market Size Growth 2017-2022 ($ Millions)
Figure 30. Brazil Bio Similars/Subsequent Entry Biologic Market Size Growth 2017-2022 ($ Millions)
Figure 31. APAC Bio Similars/Subsequent Entry Biologic Market Size Market Share by Region in 2021
Figure 32. APAC Bio Similars/Subsequent Entry Biologic Market Size Market Share by Application in 2021
Figure 33. China Bio Similars/Subsequent Entry Biologic Market Size Growth 2017-2022 ($ Millions)
Figure 34. Japan Bio Similars/Subsequent Entry Biologic Market Size Growth 2017-2022 ($ Millions)
Figure 35. Korea Bio Similars/Subsequent Entry Biologic Market Size Growth 2017-2022 ($ Millions)
Figure 36. Southeast Asia Bio Similars/Subsequent Entry Biologic Market Size Growth 2017-2022 ($ Millions)
Figure 37. India Bio Similars/Subsequent Entry Biologic Market Size Growth 2017-2022 ($ Millions)
Figure 38. Australia Bio Similars/Subsequent Entry Biologic Market Size Growth 2017-2022 ($ Millions)
Figure 39. Europe Bio Similars/Subsequent Entry Biologic Market Size Market Share by Country in 2021
Figure 40. Europe Bio Similars/Subsequent Entry Biologic Market Size Market Share by Type in 2021
Figure 41. Europe Bio Similars/Subsequent Entry Biologic Market Size Market Share by Application in 2021
Figure 42. Germany Bio Similars/Subsequent Entry Biologic Market Size Growth 2017-2022 ($ Millions)
Figure 43. France Bio Similars/Subsequent Entry Biologic Market Size Growth 2017-2022 ($ Millions)
Figure 44. UK Bio Similars/Subsequent Entry Biologic Market Size Growth 2017-2022 ($ Millions)
Figure 45. Italy Bio Similars/Subsequent Entry Biologic Market Size Growth 2017-2022 ($ Millions)
Figure 46. Russia Bio Similars/Subsequent Entry Biologic Market Size Growth 2017-2022 ($ Millions)
Figure 47. Middle East & Africa Bio Similars/Subsequent Entry Biologic Market Size Market Share by Region in 2021
Figure 48. Middle East & Africa Bio Similars/Subsequent Entry Biologic Market Size Market Share by Type in 2021
Figure 49. Middle East & Africa Bio Similars/Subsequent Entry Biologic Market Size Market Share by Application in 2021
Figure 50. Egypt Bio Similars/Subsequent Entry Biologic Market Size Growth 2017-2022 ($ Millions)
Figure 51. South Africa Bio Similars/Subsequent Entry Biologic Market Size Growth 2017-2022 ($ Millions)
Figure 52. Israel Bio Similars/Subsequent Entry Biologic Market Size Growth 2017-2022 ($ Millions)
Figure 53. Turkey Bio Similars/Subsequent Entry Biologic Market Size Growth 2017-2022 ($ Millions)
Figure 54. GCC Country Bio Similars/Subsequent Entry Biologic Market Size Growth 2017-2022 ($ Millions)
Figure 55. Americas Bio Similars/Subsequent Entry Biologic Market Size 2023-2028 ($ Millions)
Figure 56. APAC Bio Similars/Subsequent Entry Biologic Market Size 2023-2028 ($ Millions)
Figure 57. Europe Bio Similars/Subsequent Entry Biologic Market Size 2023-2028 ($ Millions)
Figure 58. Middle East & Africa Bio Similars/Subsequent Entry Biologic Market Size 2023-2028 ($ Millions)
Figure 59. United States Bio Similars/Subsequent Entry Biologic Market Size 2023-2028 ($ Millions)
Figure 60. Canada Bio Similars/Subsequent Entry Biologic Market Size 2023-2028 ($ Millions)
Figure 61. Mexico Bio Similars/Subsequent Entry Biologic Market Size 2023-2028 ($ Millions)
Figure 62. Brazil Bio Similars/Subsequent Entry Biologic Market Size 2023-2028 ($ Millions)
Figure 63. China Bio Similars/Subsequent Entry Biologic Market Size 2023-2028 ($ Millions)
Figure 64. Japan Bio Similars/Subsequent Entry Biologic Market Size 2023-2028 ($ Millions)
Figure 65. Korea Bio Similars/Subsequent Entry Biologic Market Size 2023-2028 ($ Millions)
Figure 66. Southeast Asia Bio Similars/Subsequent Entry Biologic Market Size 2023-2028 ($ Millions)
Figure 67. India Bio Similars/Subsequent Entry Biologic Market Size 2023-2028 ($ Millions)
Figure 68. Australia Bio Similars/Subsequent Entry Biologic Market Size 2023-2028 ($ Millions)
Figure 69. Germany Bio Similars/Subsequent Entry Biologic Market Size 2023-2028 ($ Millions)
Figure 70. France Bio Similars/Subsequent Entry Biologic Market Size 2023-2028 ($ Millions)
Figure 71. UK Bio Similars/Subsequent Entry Biologic Market Size 2023-2028 ($ Millions)
Figure 72. Italy Bio Similars/Subsequent Entry Biologic Market Size 2023-2028 ($ Millions)
Figure 73. Russia Bio Similars/Subsequent Entry Biologic Market Size 2023-2028 ($ Millions)
Figure 74. Spain Bio Similars/Subsequent Entry Biologic Market Size 2023-2028 ($ Millions)
Figure 75. Egypt Bio Similars/Subsequent Entry Biologic Market Size 2023-2028 ($ Millions)
Figure 76. South Africa Bio Similars/Subsequent Entry Biologic Market Size 2023-2028 ($ Millions)
Figure 77. Israel Bio Similars/Subsequent Entry Biologic Market Size 2023-2028 ($ Millions)
Figure 78. Turkey Bio Similars/Subsequent Entry Biologic Market Size 2023-2028 ($ Millions)
Figure 79. GCC Countries Bio Similars/Subsequent Entry Biologic Market Size 2023-2028 ($ Millions)
